301 related articles for article (PubMed ID: 30267378)
1. Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats.
Horst CH; Schlemmer F; de Aguiar Montenegro N; Domingues ACM; Ferreira GG; da Silva Ribeiro CY; de Andrade RR; Del Bel Guimarães E; Titze-de-Almeida SS; Titze-de-Almeida R
Neurochem Res; 2018 Nov; 43(11):2132-2140. PubMed ID: 30267378
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats.
Teerapattarakan N; Benya-Aphikul H; Tansawat R; Wanakhachornkrai O; Tantisira MH; Rodsiri R
Phytomedicine; 2018 May; 44():65-73. PubMed ID: 29895494
[TBL] [Abstract][Full Text] [Related]
3. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
[TBL] [Abstract][Full Text] [Related]
5. Selective A
Fathalla AM; Soliman AM; Moustafa AA
Neurosci Lett; 2017 Mar; 643():89-96. PubMed ID: 28213070
[TBL] [Abstract][Full Text] [Related]
6. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.
Alabi AO; Ajayi AM; Ben-Azu B; Omorobge O; Umukoro S
Metab Brain Dis; 2019 Dec; 34(6):1723-1736. PubMed ID: 31463866
[TBL] [Abstract][Full Text] [Related]
7. IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases.
Ayadi AE; Zigmond MJ; Smith AD
Exp Brain Res; 2016 Jul; 234(7):1863-1873. PubMed ID: 26894890
[TBL] [Abstract][Full Text] [Related]
8. Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson's disease.
Farombi EO; Awogbindin IO; Olorunkalu PD; Ogbuewu E; Oyetunde BF; Agedah AE; Adeniyi PA
Psychopharmacology (Berl); 2020 Nov; 237(11):3225-3236. PubMed ID: 32651640
[TBL] [Abstract][Full Text] [Related]
9. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins.
Rahimmi A; Khosrobakhsh F; Izadpanah E; Moloudi MR; Hassanzadeh K
Brain Res Bull; 2015 Apr; 113():34-40. PubMed ID: 25732239
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
12. Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7.
Wang X; Guan Q; Wang M; Yang L; Bai J; Yan Z; Zhang Y; Liu Z
Drug Des Devel Ther; 2015; 9():2553-63. PubMed ID: 26089639
[TBL] [Abstract][Full Text] [Related]
13. Phenothiazine normalizes the NADH/NAD
Tapias V; McCoy JL; Greenamyre JT
Redox Biol; 2019 Jun; 24():101164. PubMed ID: 30925294
[TBL] [Abstract][Full Text] [Related]
14. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
Javed H; Azimullah S; Meeran MFN; Ansari SA; Ojha S
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934738
[TBL] [Abstract][Full Text] [Related]
16. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407
[TBL] [Abstract][Full Text] [Related]
17. Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Mol Neurobiol; 2018 May; 55(5):4078-4089. PubMed ID: 28585189
[TBL] [Abstract][Full Text] [Related]
18. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
Tapias V; Cannon JR; Greenamyre JT
J Neurosci Res; 2010 Feb; 88(2):420-7. PubMed ID: 19681169
[TBL] [Abstract][Full Text] [Related]
19. miR-185 and SEPT5 Genes May Contribute to Parkinson's Disease Pathophysiology.
Rahimmi A; Peluso I; Rajabi A; Hassanzadeh K
Oxid Med Cell Longev; 2019; 2019():5019815. PubMed ID: 31814881
[TBL] [Abstract][Full Text] [Related]
20. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
Liu H; Jia L; Chen X; Shi L; Xie J
Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
